Quantitation and Spatial Registration of Airways Dysfunction With Dynamic 19F MRI in Cystic Fibrosis

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 20, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cystic FibrosisVentilatory Defect
Interventions
COMBINATION_PRODUCT

19F MRI

Inhalation of a biologically inert contrast gas, perfluoropropane, combined with 19F-tuned MRI with image acquisition at breath-hold and during tidal breathing

Trial Locations (1)

27514

RECRUITING

Univeristy of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Cystic Fibrosis Foundation

OTHER

lead

University of North Carolina, Chapel Hill

OTHER